Sinina, Valerie Claire L.
HRN: 12-56-28 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/08/2024
CEFUROXIME 750MG (VIAL)
06/08/2024
06/15/2024
IV
500mg
Q8
Abrasion Tempoparietal Area R
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft TissueProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes